|
Petition for ORAL TREATMENT |
 |
 |
 |
|
Thursday, 28 February 2013 12:12 Written by Linda McInnes
|
|
Go to http://www.hepc-cured.org and sign the White House petition.
Expedite Cure for Hepatitis C - Drug Companies Hold the Cure (without toxic ribavirin or interferon)
Hepatitis C infects almost 4 million Americans and more than 170 million people worldwide, and it now kills more people than AIDS.
Now a safe 100% cure exists, without toxic ribavirin or interferon, but is being held back by 'big pharma'. Immediate action is required to facilitate collaboration between the drug companies with this cure.
Created: Feb 19, 2013
http://www.prweb.com/releases/2013/2/prweb10442889.htm
We want this cure NOW! Save those with Hepatitis C NOW!
Help eliminate Hepatitis C, America’s ‘silent epidemic.’ We are taking the next step by launching a new petition drive on the White House website. We are asking the President to encourage Gilead Sciences, Inc., in cooperation with Bristol-Myers Squibb, to proceed with Phase 3 trials to bring their ground-breaking cure for Hepatitis C virus (HCV) to market. This will lead to Food and Drug Administration approval so that their two drugs in combination are available to save those dying from HCV.
In November 2012, Bristol-Myers Squibb (BMS) announced it achieved a 100 percent cure rate for HCV. In phase two trials, Bristol Myers-Squibb, using its drug Daclatasvir in combination with sofosbuvir from Gilead Sciences, achieved a major milestone: the 100 percent cure rate for HCV: type 1 with similar results with the same drugs for HCV: type 2 and HCV: type 3. The two companies each own a drug that in combination has cured hepatitis patients within 12 weeks. The results of the all-oral combination are a huge advance, not only due to the remarkable results, but because they had mild side effects (mild to moderate fatigue, headache, nausea) that were well tolerated.
Hepatitis C Virus is a blood-borne disease that attacks the liver. It can be fatal and is linked to 12,000 U.S. deaths a year. The traditional two-drug chemo-style treatments for the virus cure only about 40 percent of people. It is not always effective and causes side effects like severe anemia, nausea, fatigue, vomiting, amnesia, weight loss, and body aches that can be disabling. HCV also can be a silent killer, destroying a person’s liver over years without any symptoms. The Centers for Disease Control recently issued a warning and recommends that everyone between the ages of 45 and 65 be tested. Millions more could have the virus and not know it.
This petition is about a cure for the disease — a cure that exists, but is not available to patients who need it.
The two big pharmaceutical companies have yet to take the final step together to get this cure to market. Each has unsuccessfully tried to replicate the other’s matching drug rather than working together on what is sure to work best. Bristol Myers-Squibb is eager to work with Gilead, but Gilead is not interested. Dr. Douglas J. Manion, a senior vice president for Bristol-Myers, said his company was “keen” on working with Gilead but “thus far, they have been unwilling to engage in that collaboration.”
President Obama could use his power to provide incentives to the drug companies which would encourage them to end this standoff and move forward to save lives. If the two companies do not collaborate, a new successful cocktail of drugs that works could take years, time many patients do not have.
Once approved for use, this treatment can cure millions of people worldwide. To think the cure everybody has been praying for is here, but not available because of corporate greed is shocking. Why are they still chasing the cure when they have already found it?
I hope people will be as outraged by this as we are; please sign the petition and share it with your friends—now!
http://www.prweb.com/releases/2013/2/prweb10442889.htm
Add this page to your favourite Social Bookmarking websites;        
 
 |
